Amneal Pharmaceuticals (AMRX) earnings per share (EPS)

Earnings per share · fiscal 2025
$0.22

Amneal Pharmaceuticals (AMRX) reported diluted earnings per share of $0.22 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$0.38. Figures as of 17 Nov 2026, 21:32 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
$0.22
Growth, 5 years
−18.5% a year
Highest on record
$0.61fiscal 2020
Lowest on record
-$2.74fiscal 2019
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Amneal Pharmaceuticals earnings per share (EPS), in more detail

Over the five fiscal years to 2025 diluted earnings per share shrank at a compound 18.5% a year. Across the 8 fiscal years on record (2018–2025), the highest was $0.61 in fiscal 2020 and the lowest -$2.74 in fiscal 2019.

History · 8 fiscal years

Earnings per share by fiscal year

Amneal Pharmaceuticals earnings per share (EPS), year by year

Amneal Pharmaceuticals (AMRX) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025$0.22—
2024-$0.38—
2023-$0.48—
2022-$0.86 1,328.6% down
2021$0.07 88.5% down
2020$0.61—
2019-$2.74—
2018-$0.16—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Amneal Pharmaceuticals and comparable companies
CompanyEarnings per shareFiscal year
Cytokinetics CYTK-$6.542025
ABIVAX ABVX-€4.832025
Bausch + Lomb BLCO-$1.022025
Amneal Pharmaceuticals AMRX$0.222025
Caris Life Sciences CAI-$3.222025
Immunovant IMVT-$2.772026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on AMRX

Amneal Pharmaceuticals, figure by figure

Amneal Pharmaceuticals (AMRX) overview: price, valuation and scorecardAll health care companies by market value

Amneal Pharmaceuticals earnings per share (EPS): questions and answers

What is Amneal Pharmaceuticals's diluted earnings per share?

Amneal Pharmaceuticals (AMRX) reported diluted earnings per share of $0.22 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$0.38.

What is the growth rate of Amneal Pharmaceuticals's diluted earnings per share?

Over the five fiscal years to 2025 diluted earnings per share shrank at a compound 18.5% a year.

What are the highest and lowest diluted earnings per share figures on record for Amneal Pharmaceuticals?

Across the 8 fiscal years on record (2018–2025), the highest was $0.61 in fiscal 2020 and the lowest -$2.74 in fiscal 2019.

How is Amneal Pharmaceuticals's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Amneal Pharmaceuticals (AMRX) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/AMRX/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.